Bionomics Limited has successfully concluded two Phase 1b clinical trials of BNC210 which is being developed as a new generation treatment for anxiety and depression.
Nycomed announced plans for a phase 3/4 study investigating the effect of Daxas versus placebo on exacerbation rates in COPD patients who are concomitantly treated with fixed combination long-acting-ß2-agonists and inhaled corticosteroids.
The PHOENIX trial is a placebo-controlled Phase 3 study treating catecholamine-resistant patients in distributive shock with the nitric oxide scavenger pyridoxalated hemoglobin polyoxyethylene conjugate.
GlaxoSmithKline PLC says its seizure drug developed with Valeant Pharmaceuticals Inc. has been granted marketing authorization by the European Union. Trobalt is intended to treat partial onset seizures in adults with epilepsy.
TAP Biosystems, a supplier of innovative automation and consumables for life science applications, announced it is introducing a 96-well version of its RAFT system for the generation of consistent multi-cellular 3D tissue models.
GE Healthcare’s IN Cell Analyzer 6000 is a laser-based, confocal imaging platform designed for demanding high-content cellular assays and screens including live cell assays, 3D imaging, co-localization studies and imaging of assays with low signal.
Engineers have invented a new kind of nano-particle that shines in different colors to tag molecules in biomedical tests. These tiny plastic nano-particles are stuffed with even tinier bits of electronics called quantum dots.
In what they described as the opening of a new era in the development of potentially life-saving new drugs, scientists reported discovery of a way to tone down an overactive gene involved in colon cancer and block a key protein involved in asthma attacks.
EMD Millipore launched its new SignalProfiler Services. Researchers can use these new services to profile the safety and efficacy of potential drug compounds against multiple signaling pathways using their choice of cell types.
INC Research, LLC announced it has released a new white paper entitled, “Win with Networked Drug Development Alliances: New Strategies to Increase Productivity and Mitigate Risk.”
Graceway Pharmaceuticals announced that the Food and Drug Administration has approved Zyclara Cream for the treatment of external genital and perianal warts in patients 12 years of age and older.
Genentech announced that the second of two Phase 3 trials evaluating Lucentis in patients with diabetic macular edema met its primary endpoint. The primary endpoint was the ability to read at least 15 additional letters on an eye chart.
Severe hypertriglyceridemia, or very high triglycerides (?500 mg/dL), is a serious and growing lipid disorder that currently impacts more than five million Americans and is associated with an increased risk of pancreatitis and heart disease.
The tremendous pressures on pharmaceutical company pipelines are always in the news. Constant reorganizations and acquisitions of late-stage clinical candidates or of entire companies are seen as a major solution going forward.
When a tablet of medicine is taken, the active molecules get absorbed into the bloodstream through the gut and make their way around the body, including to the cells in which they are intended to act; however, it's important they don't stay in the body forever.